
| Salt Composition: | Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg) |
| Manufacturer: | Cadell Healthcare Pvt Ltd |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Volpost GM 1mg/500mg/0.2mg Tablet is an anti-diabetic drug used to treat type 2 diabetes mellitus in adults by controlling blood sugar levels. Volpost GM 1mg/500mg/0.2mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. The medicine should be taken with food to avoid an upset stomach. It can cause hypoglycemia when used with other antidiabetic medicines, alcohol, or if meals are delayed or missed. Regular liver function checks may be necessary, and any symptoms such as abdominal pain, loss of appetite, or jaundice should be reported to a doctor. The medicine is generally considered unsafe during pregnancy and breastfeeding, and alcohol consumption should be avoided.
Volpost GM 1mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines.
What is Volpost GM 1mg/500mg/0.2mg Tablet?
Volpost GM 1mg/500mg/0.2mg Tablet is a combination medication containing Glimepiride, Metformin, and Voglibose. It is used to treat type 2 diabetes mellitus (DM) in adults, in conjunction with a healthy diet and regular exercise. Glimepiride increases insulin release from the pancreas, Metformin reduces glucose production in the liver and improves insulin sensitivity, and Voglibose lowers postprandial glucose levels. This medication is not suitable for treating type 1 DM.
What are the possible side effects of Volpost GM 1mg/500mg/0.2mg Tablet?
Common side effects of Volpost GM 1mg/500mg/0.2mg Tablet include hypoglycemia (low blood sugar level), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. If you experience any of these symptoms, consult your doctor or healthcare professional for guidance.
Are there any specific conditions in which Volpost GM 1mg/500mg/0.2mg Tablet should not be taken?
Volpost GM 1mg/500mg/0.2mg Tablet should be avoided in patients with known allergies to its components or excipients. Additionally, it is contraindicated in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis.
Is it safe to take alcohol while I am also taking Volpost GM 1mg/500mg/0.2mg Tablet?
No, it is not recommended to consume alcohol while taking Volpost GM 1mg/500mg/0.2mg Tablet. This may increase the risk of hypoglycemia and lactic acidosis. Consult your doctor or healthcare professional for personalized advice on medication and alcohol use.
Can the use of Volpost GM 1mg/500mg/0.2mg Tablet cause hypoglycemia?
Yes, Volpost GM 1mg/500mg/0.2mg Tablet can cause hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. Regular monitoring of blood sugar levels is crucial, especially when taking this medication. Always keep glucose tablets, honey, or fruit juice readily available.
What are the instructions for the storage and disposal of Volpost GM 1mg/500mg/0.2mg Tablet?
Store Volpost GM 1mg/500mg/0.2mg Tablet in its original packaging, tightly closed. Dispose of unused medication properly, ensuring it is not consumed by pets, children, or other individuals.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Volpost GM 1mg/500mg/0.2mg Tablet is to be taken on an empty stomach.
Alcohol
It is unsafe to consume alcohol with Volpost GM 1mg/500mg/0.2mg Tablet.
Breastfeed
Volpost GM 1mg/500mg/0.2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy
Volpost GM 1mg/500mg/0.2mg Tablet may be unsafe to use during pregnancy. Consult your doctor for more information.